SCHEMBL31306166

SCHEMBL31306166

C=Cc1cc(F)c(F)cc1C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
PDK2 Q15119 1/20 0.38
PDK4 Q16654 1/20 0.38
KDM4E B2RXH2 5/20 0.37
GAA P10253 4/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
POLB P06746 1/20 0.37
NFKB1 P19838 1/20 0.37
XDH P47989 1/20 0.37
GFER P55789 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
FUT7 Q11130 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24746194 0.89 SOS1 (0.40) CA12CA1CA2CA7CA9
SCHEMBL34465654 0.89 KDM4E (0.42) KDM4EGAALMNAPOLBALDH1A1
SCHEMBL22802075 0.88 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL10290728 0.84 CYP3A4 (0.38) CA12CA1CA2CA7CA9
SCHEMBL31306269 0.83 ERN1 (0.48) CA12CA1CA2CA7CA9
SCHEMBL17262480 0.83 CYP3A4 (0.37) CA12CA1CA2CA7CA9
SCHEMBL20156870 0.82 CA12 (0.36) CA12CA1CA2CA7CA9
SCHEMBL8815451 0.82 SLC6A4 (0.45) CA12CA1CA2CA7CA9
SCHEMBL20511627 0.82 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL15103338 0.81 PDGFRB (0.45) LMNAPOLBTDP1ERN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4734979-A2 TMEM175 AGONISTS, COMPOSITIONS, AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2026-05-06 EP disclosed
WO-2025006723-A2 TMEM175 AGONISTS, COMPOSITIONS, AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2025-01-02 WO disclosed